vs
Side-by-side financial comparison of Celcuity Inc. (CELC) and GRAIL, Inc. (GRAL). Click either name above to swap in a different company.
Celcuity Inc. is a clinical-stage biotechnology company specializing in oncology. It develops personalized cancer treatment solutions through its proprietary functional cell analysis technology, targeting unmet medical needs for patients with hard-to-treat solid tumors, with primary operations in the U.S. and partnerships across global biopharmaceutical networks.
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $43.6M | ||
| Q3 25 | — | $36.2M | ||
| Q2 25 | — | $35.5M | ||
| Q1 25 | — | $31.8M | ||
| Q4 24 | — | $38.3M | ||
| Q3 24 | — | $28.7M | ||
| Q2 24 | — | $32.0M | ||
| Q1 24 | — | $26.7M |
| Q4 25 | — | $-99.2M | ||
| Q3 25 | — | $-89.0M | ||
| Q2 25 | — | $-114.0M | ||
| Q1 25 | — | $-106.2M | ||
| Q4 24 | — | $-97.1M | ||
| Q3 24 | — | $-125.7M | ||
| Q2 24 | — | $-1.6B | ||
| Q1 24 | — | $-218.9M |
| Q4 25 | — | -285.4% | ||
| Q3 25 | — | -346.2% | ||
| Q2 25 | — | -446.9% | ||
| Q1 25 | — | -482.5% | ||
| Q4 24 | — | -358.0% | ||
| Q3 24 | — | -640.5% | ||
| Q2 24 | — | -5133.8% | ||
| Q1 24 | — | -851.1% |
| Q4 25 | — | -227.5% | ||
| Q3 25 | — | -245.8% | ||
| Q2 25 | — | -320.7% | ||
| Q1 25 | — | -333.6% | ||
| Q4 24 | — | -253.8% | ||
| Q3 24 | — | -438.7% | ||
| Q2 24 | — | -4958.8% | ||
| Q1 24 | — | -819.3% |
| Q4 25 | — | $-2.37 | ||
| Q3 25 | — | $-2.46 | ||
| Q2 25 | — | $-3.18 | ||
| Q1 25 | — | $-3.10 | ||
| Q4 24 | — | $-1.49 | ||
| Q3 24 | — | $-3.94 | ||
| Q2 24 | — | $-51.06 | ||
| Q1 24 | — | $-7.05 |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
